Q2 2026 Astrana Health Inc Earnings Call Transcript
Key Points
- Astrana Health Inc (ASTH) delivered strong Q2 2026 results with revenue up 49% year-over-year to $973 million and adjusted EBITDA up 43% to $69 million, with record adjusted EPS of $0.80.
- The company's AI-native operating system is driving significant operational efficiencies, including a 50% reduction in claims handling time and G&A as a percentage of revenue improving by 210 basis points year-over-year.
- Astrana Health Inc (ASTH) exceeded its deleveraging commitment ahead of schedule, reducing net leverage to 2.26x on a trailing 12-month basis, well below the 2.5x target set for 24 months.
- The company raised its full-year 2026 adjusted EBITDA guidance to $255-$280 million, reflecting broad-based outperformance and continued maturation of full-risk cohorts.
- Astrana Health Inc (ASTH) continues to expand its footprint with new Medicare Advantage agreements in Hawaii and Texas, and is seeing strong demand across its payer and provider pipelines.
- The Prospect integration is progressing well, with gross provider retention above 99% and operating expense synergies expected at the high end of the $12-$15 million annual target.
- Astrana Health Inc (ASTH) experienced a one-time $15 million revenue reduction in Q2 2026 related to CMS's implementation of adjustments for significant anomalous and highly suspect billing activity for the ACO REACH 2025 performance year.
- Commercial medical cost trend ran slightly above expectations during the quarter, concentrated in certain outpatient specialties, though management believes it is manageable.
- The company continues to face Medicaid-related membership attrition, tracking toward the high end of expectations, with adverse selection remaining a concern.
- Astrana Health Inc (ASTH) is deliberately reinvesting a substantial portion of its outperformance (mid to high single-digit millions) into growth opportunities, which may delay near-term earnings acceleration.
- The company's Q4 2026 EBITDA guidance range is wide ($47-$67 million), implying a meaningful sequential step-down from Q3 levels, which may signal uncertainty in the back half of the year.
- Astrana Health Inc (ASTH) continues to plan conservatively with zero contribution from HQOF and conservative Medicaid membership trends, indicating potential headwinds that could impact future performance.
Hello, everyone, and welcome to Astrana Health's second quarter 2026 earnings call. At this time, all participants are in the listen-only mode. Later, you will have the opportunity to ask questions during the question-and-answer session, and instructions will be provided at that time.
Today's speakers will be Brandon Sim, President and Chief Executive Officer of Astrana Health, and Chikam Basho, Chief Operating and Financial Officer.
The press release announcing Astrana Health's results for the second quarter ended June 30, 2026, is available in the Investor Relations section of the company's website at www.astranahealth.com. The company will discuss certain non-GAAP measures during this call. Reconciliations to the most comparable GAAP measures are included in the press release. To provide some additional background on the results, the company has made a. Supplemental deck available on its website.
A replay of this broadcast will be available at Estrada Health's website after the conclusion of this call.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
